CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma. Monther A, Al-Msari R, Saddawi-Konefka R, Fassardi S, et al. PLoS One 2026;21:e0328031.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Monther A, Al-Msari R, Saddawi-Konefka R, Fassardi S, et al. CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma. PLoS One 2026;21:e0328031.
PMID: 41701713